LRRC45: A Potential Drug Target and Biomarker (G201255)

Target Name: LRRC45

NCBI ID: G201255

LRRC45

Other Name(s): leucine rich repeat containing 45 | leucine-rich repeat-containing protein 45 | Leucine-rich repeat-containing protein 45 | LRC45_HUMAN | Leucine rich repeat containing 45

LRRC45: A Potential Drug Target and Biomarker

LRRC45, also known as leucine rich repeat containing 45, is a protein that is found in various cell types throughout the body. It is characterized by the presence of a specific repeat sequence, known as a leucine rich repeat, which is a common feature in proteins that are involved in various cellular processes.

Recent studies have identified LRRC45 as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. This is due to its involvement in various cellular processes that are associated with the development and progression of these diseases.

One of the key mechanisms by which LRRC45 is involved in disease is its role in the regulation of cell signaling pathways. LRRC45 has been shown to play a role in the regulation of several signaling pathways, including the TGF-β pathway, the PI3K/Akt pathway, and the NF-kappa-B pathway. These pathways are involved in various cellular processes, including cell growth, differentiation, and inflammation.

In addition to its role in cell signaling pathways, LRRC45 has also been shown to play a role in the regulation of gene expression. Studies have shown that LRRC45 can interact with certain genes and regulate their expression, which can have a significant impact on cellular processes and overall cellular function.

LRRC45 has also been shown to be involved in the regulation of cellular processes that are important for maintaining tissue homeostasis. This includes its role in the regulation of cell adhesion, migration, and the maintenance of tight junctions, which are important for the proper functioning of tissues and organs.

In conclusion, LRRC45 is a protein that has been identified as a potential drug target and biomarker for a variety of diseases. Its involvement in cell signaling pathways, gene expression, and cellular homeostasis makes it an attractive target for researchers and clinicians who are seeking new treatments for these diseases. Further research is needed to fully understand the role of LRRC45 in disease and to develop safe and effective treatments.

Protein Name: Leucine Rich Repeat Containing 45

Functions: Component of the proteinaceous fiber-like linker between two centrioles, required for centrosome cohesion

The "LRRC45 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LRRC45 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets